The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Somaiya Mayur Ian since 2020.
This trader's CIK number is 1760303.
At the time of last reporting, Somaiya Mayur Ian was the Chief Financial Officer of Newamsterdam Pharma Co N.v.. (stock ticker symbol NAMS).
Also see all insider trading activities at Newamsterdam Pharma Co N.v..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2026 | NAMS | 0 | $0 | 5,118 | $170,173 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2020 | TCRR | 0 | $0 | 5,666 | $179,980 | 4,000 | $23,520 |
1. Newamsterdam Pharma Co N.v. (NAMS)
2. Tcr2 Therapeutics Inc. (TCRR)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-01-05 | NAMS | Sale | 5,118 | 33.25 | 170,173 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-12-14 | TCRR | Sale | 2,000 | 35.00 | 70,000 |
| 2020-12-14 | TCRR | Option Ex | 2,000 | 5.88 | 11,760 |
| 2020-11-17 | TCRR | Sale | 3,666 | 30.00 | 109,980 |
| 2020-11-17 | TCRR | Option Ex | 2,000 | 5.88 | 11,760 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Somaiya Mayur Ian (Chief Financial Officer of Newamsterdam Pharma Co N.v. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.